Has Bhupinder Bhandari received payments from drug or device companies?

Yes. Drug and device makers reported $9,603 in general payments to Bhupinder Bhandari across 328 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bhupinder Bhandari did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bhupinder Bhandari come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bhupinder Bhandari

Gastroenterology · Fremont, CANPI 1417068511

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,804 of the $9,603 with a category attached, or 70.9%. 49 manufacturers reported payments, led by Gilead at 32.0% of the total. Reporting peaked in 2019 at $3,748 and has fallen 94.9% since, to $192 in 2025.

$9,603in general payments, 2019–2025

Across 328 payments — averaging $29.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Gilead$3K
Novo Nordisk$1K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$563
AbbVie$438
Pfizer$374
Otsuka America Pharmaceutical, Inc.$320
plus $4K from 43 others

What the payments were for

Consulting fees$2,40025%
Travel & lodging$2533%
Food & beverage$6,80471%
Education$210%
Gifts$1251%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Gilead	34	$3,071
Novo Nordisk	81	$1,215
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	9	$563
AbbVie	19	$438
Pfizer	18	$374
Otsuka America Pharmaceutical, Inc.	20	$320
Lilly USA, LLC	12	$282
Johnson & Johnson(3 entities)	14	$278
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	16	$271
Merck	6	$256
AstraZeneca	13	$254
Axsome Therapeutics, Inc.	5	$217
Takeda Pharmaceuticals U.S.A., Inc.	6	$185
Braintree Laboratories, Inc.	4	$165
Teva Pharmaceuticals USA, Inc.	2	$130
Neurocrine Biosciences, Inc.	5	$117
Amgen	4	$109
Collegium Pharmaceutical, Inc.	6	$106
Capsopro Services LLC	1	$100
Intercept Pharmaceuticals, Inc.	4	$97
Biotronik Inc.	1	$79
Dexcom, Inc.	4	$78
Boehringer Ingelheim	3	$74
Astellas Pharma US Inc	4	$70
Biohaven Pharmaceuticals, Inc.	4	$65
Biohaven Pharmaceutical Holding Company Ltd.	3	$59
Pentax Of America, Inc.	1	$55
Ironwood Pharmaceuticals, Inc	3	$50
Sun Pharmaceutical Industries Inc.	2	$43
Boston Scientific	2	$40
Nestle Healthcare Nutrition Inc.	3	$38
Bristol Myers Squibb	2	$36
Insmed, Inc.	1	$32
Ardelyx, Inc.	1	$31
Kowa Pharmaceuticals America, Inc.	1	$29
GSK	1	$28
Novartis	1	$24
E.r. Squibb & Sons, L.L.C.	1	$24
Scilex Pharmaceuticals Inc.	1	$23
Daiichi Sankyo Inc.	1	$22
Lifescan, Inc.	1	$21
Abbott	1	$21
Hikma Pharmaceuticals USA	1	$21
Sanofi-aventis U.S. LLC	1	$21
Amarin Pharma, Inc.	1	$19
Bayer	1	$16
Alfasigma USA, Inc.	1	$15
Endogastric Solutions, Inc	1	$14
Heron Therapeutics, Inc.	1	$4

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Vemlidy$2,553
STEGLATRO$164
Auvelity$116
LifeVest$102
AJOVY$101

How this compares

$9,603 in reported general payments places this provider in the 80th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California →

Other gastroenterology in Fremont

Bennett RothLos Angeles$2.8M
Douglas NguyenMission Viejo$2M
Sammy SaabLos Angeles$1.9M
Kenneth ChangNewport Beach$1.3M
Joo HwangStanford$1M
Drew SchembreWalnut Creek$659K
Quan Nhula Jolla$641K
Sadeea AbbasiLos Angeles$556K
Ali RezaieWest Hollywood$519K
Kenneth BinmoellerSan Francisco$507K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →